http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1152697-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_273fb2da35d32004cc7180a5132d9c41 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-482 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate | 1966-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1969-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1152697-A |
| titleOfInvention | Improvements in or relating to Therapeutic Compositions |
| abstract | 1,152,697. Therapeutic compositions. DENVER CHEMICAL MFG. CO. 27 May, 1966 [18 June, 1965], No. 23799/66. Heading A5B. Orally administrable therapeutic compositions comprise a mixture of a psychopharmacological drug (chosen from anti-depressants, tranquilizers and central nervous system stimulants) and an enteric coated proteolytic enzyme or hyaluronidase, but excluding any content of a pantothenyl-group-containing compound. The proteolytic enzyme may be trypsin, papain, bromelain, ficin, streptokinase, penguinan, collagenase derived from Clostridium hystolyticum, a protease derived from Bacillus subtilis, Asper gillus oryzae, Aspergillus niger or Microsporon gypseum or preferably chymotryspin. The psychopharmacological drug may be a phenothiazine derivative such as chlorpromazine, prochlorperazine, promethazine, promazine, mepazine, pyrathiazine, diethazine, perphenazine; thiopropazole, trimeprazine, trifluoperazine or trifluopromazine; a Rauwolfia alkaloid, e.g. reserpine, rescinnamine, syrosingopine or deserpidine, C.N.S. stimulants such as dextroamphetamine, methylphenidyl acetate, pipradol, azacyclonal or other tranquilizers or anti-depressants such as covatin, hydroxyzine, bentactyzine, dimethylyn, meprobamate or imipramine. The composition may be in the form of gelatin capsules or tablets comprising a core containing the enzyme coated with an enteric substance such as cellulose acetate phthalate or shellac and further comprising a compressed or sugar coating containing the psychopharmacological drug. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2231263-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2659200-C1 |
| priorityDate | 1965-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.